Pennine Acute is First NHS Trust to Install iSOFT's e-Prescribing Solution

iSOFTThe Pennine Acute Hospitals NHS Trust has become the first NHS trust to install the e-prescribing and medicines administration (ePMA) solution from iSOFT, a CSC company, after an initial implementation at The Royal Oldham Hospital, under plans to transform and improve patient safety and clinical outcomes across the trust.

ePMA is installed on elderly rehabilitation wards at The Royal Oldham, with doctors, nurses and pharmacists using the software to improve the management of medicines. Following this proof of concept phase, the solution will be rolled out across numerous specialties at the trust's four main hospitals, including A&E, medical assessment unit, oncology and surgical wards, under plans for a trust-wide implementation.

Pennine Acute's associate director of IM&T, Christine Walters, said: "ePMA is a key building block for our strategy to implement a comprehensive electronic patient record. We have undertaken a thorough baseline performance review prior to implementation and we are expecting to able to show benefits relating to patient safety, clinical outcomes and operational efficiency. Early signs are very encouraging."

ePMA is part of a larger programme at Pennine Acute. iSOFT is also delivering a number of integrated clinical solutions, including order communications and results reporting, electronic whiteboards, clinical documentation and a clinical portal.

"This is a clear sign that Pennine continues to gain real value from its partnership with iSOFT and now CSC," said Adrian Stevens, managing director of iSOFT's UK and Ireland business. "Our solution offers substantial benefits in terms of patient safety and patient care and will make a real and lasting difference to clinical staff."

iSOFT ePMA provides new opportunities to improve the communication of medicines related information between medical, nursing and clinical pharmacy teams. Advanced drug formulary management underpinned by clinical and workflow based decision support provides a highly effective environment to help improve a hospital's performance in relation to medicines. In-built reporting and data analysis tools provide executive and management visibility of performance to help proactively address areas of concern or promote good practice.

Proven at large acute and specialist hospitals in Australia and New Zealand, iSOFT ePMA is shown to halve adverse medication errors that can prolong a patient's stay by up to four days, and so block hospital beds and increase costs.

Related news articles:

About CSC
CSC is a global leader in providing technology-enabled business solutions and services. Headquartered in Falls Church, Va., CSC has approximately 93,000 employees and reported revenue of $16.2 billion for the 12 months ended July 1, 2011.

Most Popular Now

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

OmicsFootPrint: Mayo Clinic's AI To…

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The details of the tool...

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

Testing AI with AI: Ensuring Effective A…

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialled in South Australian hospitals actually has the potential to assist doctors and...

AI Unlocks Genetic Clues to Personalize …

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes - insights that could help doctors tailor...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

Deep Learning to Increase Accessibility…

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...